|
|
News & Events
News
|
10-Jun-2010
The Symposium was held on 17 May 2010 in Montpellier, France. The overall goal of the meeting was to devise the first draft of a policy agenda and recommendations on how genomics can boost the development of the bioeconomy. The main messages which came out of the meeting were the need for guidelines on international cooperation in genomics R&D; the need to further advance the areas of genomics through innovative IPR management models; and the need for innovative approaches to measure the economic impact of genomics.
|
|
02-Jun-2010
The first version of the OECD Environmental Risk Assessment Toolkit is now available. This Toolkit describes the work flow of environmental risk assessment and management with links to relevant OECD products that can be used in each step of the work flow. This Toolkit provides support for capacity building to relevant stakeholders by improving the access and use of various tools and guidance on risk assessment and management of chemicals developed under the OECD Environment, Health and Safety Programme.
|
|
28-May-2010
An internet-based public discussion forum for users of the OECD (Q)SAR Application Toolbox is now available. The (Q)SAR Application Toolbox is a software application intended to be used by governments, industry and other stakeholders to fill gaps in (eco)toxicity data needed for assessing the hazards of chemicals. On this discussion forum, users of the Toolbox can exchange experience with using the software (tips and tricks), seek guidance, exchange databases, exchange user defined profilers and QSARs, and make suggestions for improvements.
|
|
06-May-2010
This symposium aimed to contribute to fostering the safe and efficient development of this new field by identifying issues and areas for future study.
|
|
11-Mar-2010
The main objective of the workshop was to develop a short data intensive report, the OECD Outlook on Industrial Biotechnology. This OECD Outlook is intended to provide data and information on a number of Industrial Biotechnology-related trends and issues. It is expected that the themes addressed during the workshop will also provide the basis for creation of datasets and indicators to improve evidence-based policy making.
|
|
18-Nov-2009
This new book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
|
Top of page
|
Policy Brief - Health
|
